U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07301619) titled 'Post-market Study on BtHCROSS(R) for Restoring Facial Volume After a Single Injection' on Nov. 27.
Brief Summary: This clinical study investigated the safety and effectiveness of BtHCROSS, a hyaluronic acid-based injectable used to restore facial volume and reduce wrinkles. Adults aged 30 to 70 received a single treatment and were monitored over 9 months. Researchers assessed improvements in facial appearance and recorded any side effects. The results aimed to support the product's continued safe use in aesthetic treatments.
Study Start Date: April 26, 2022
Study Type: INTERVENTIONAL
Condition:
Aesthetics Procedure
Intervention...